Pricing and Procurement: Navigating the Challenges of Volume-Based Purchasing in China's Biologics Landscape
One of the most defining—and challenging—features of the commercial landscape within the **China Biologics Market** is the pervasive influence of the Volume-Based Procurement (VBP) policy. VBP is a state-led mechanism designed to drive down the cost of medicines by leveraging the immense volume of the national market. Under VBP, manufacturers compete to supply large quantities of a...
0 Commentaires 0 Parts 351 Vue 0 Aperçu